Patents Assigned to STEM CELL MEDICINE LTD.
  • COSMETIC COMPOSITIONS WITH PROTEIN CONCENTRATE FROM CONDITIONED MEDIUM OF ADIPOSE-DERIVED STEM CELLS
    Publication number: 20230018711
    Abstract: Anti-aging cosmetic compositions prepared from conditioned medium of adipose-derived stem cells are provided. The cosmetic compositions are preferably ready-to-mix compositions, comprising two separate components: a protein component in a dried form that serves as the cosmetically active ingredient of the product, comprising a protein fraction purified from an adipose-derived stem cell conditioned medium; and a reconstitution component, for reconstituting the lyophilized protein component just before application to the skin.
    Type: Application
    Filed: January 19, 2021
    Publication date: January 19, 2023
    Applicant: STEM CELL MEDICINE LTD.
    Inventors: Yona GEFFEN, Ehud MAROM
  • Treatment of multiple sclerosis with adipose-derived stem cells
    Patent number: 11510946
    Abstract: Methods of treating progressive forms of multiple sclerosis are provided, comprising administering adipose-derived stem cells into the central nervous system (CNS). Further provided are improved methods for obtaining ADSCs, which are more cost effective and which provide higher yields compared to currently used methods.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: November 29, 2022
    Assignee: STEM CELL MEDICINE LTD.
    Inventors: Ehud Marom, Frida Grynspan, Dima Yudin
  • Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
    Patent number: 11413311
    Abstract: Methods of treating multiple sclerosis are provided, comprising parenterally administering glatiramer acetate in a sustained-release depot form, and administering adipose-derived stem cells into the central nervous system. According to some aspects the combined treatments provide synergistic effects. In particular the combined therapies offer benefits to progressive forms of multiple sclerosis.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: August 16, 2022
    Assignees: MAPI PHARMA LTD., STEM CELL MEDICINE LTD.
    Inventors: Ehud Marom, Nadav Bleich Kimelman, Frida Grynspan
  • TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH LONG ACTING GLATIRAMER AND ADIPOSE-DERIVED STEM CELLS
    Publication number: 20210220428
    Abstract: Methods for treating inflammatory bowel disease are provided, comprising administration of glatiramer acetate in a sustained-release depot form and administration of adipose-derived stem cells.
    Type: Application
    Filed: June 29, 2017
    Publication date: July 22, 2021
    Applicants: STEM CELL MEDICINE LTD., MAPI PHARMA LTD.
    Inventors: Ehud MAROM, Nadav BLEICH KIMELMAN, Frida GRYNSPAN
  • TREATMENT OF MULTIPLE SCLEROSIS WITH ADIPOSE-DERIVED STEM CELLS
    Publication number: 20200188439
    Abstract: Methods of treating progressive forms of multiple sclerosis are provided, comprising administering adipose-derived stem cells into the central nervous system (CNS). Further provided are improved methods for obtaining ADSCs, which are more cost effective and which provide higher yields compared to currently used methods.
    Type: Application
    Filed: May 14, 2018
    Publication date: June 18, 2020
    Applicant: STEM CELL MEDICINE LTD.
    Inventors: Ehud MAROM, Frida GRYNSPAN, Dima YUDIN
  • TREATMENT OF MULTIPLE SCLEROSIS WITH LONG ACTING GLATIRAMER AND ADIPOSE-DERIVED STEM CELLS
    Publication number: 20200147141
    Abstract: Methods of treating multiple sclerosis are provided, comprising parenterally administering glatiramer acetate in a sustained-release depot form, and administering adipose-derived stem cells into the central nervous system. According to some aspects the combined treatments provide synergistic effects. In particular the combined therapies offer benefits to progressive forms of multiple sclerosis.
    Type: Application
    Filed: May 15, 2017
    Publication date: May 14, 2020
    Applicants: STEM CELL MEDICINE LTD., MAPI PHARMA LTD.
    Inventors: Ehud MAROM, Nadav BLEICH KIMELMAN, Frida GRYNSPAN
  • Beta-lactam compounds for treating diabetes
    Patent number: 9474744
    Abstract: Compositions and methods comprising ampicillin or salts and derivative thereof for the treatment of delaying the onset of type I diabetes are provided.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: October 25, 2016
    Assignee: STEM CELL MEDICINE LTD.
    Inventors: Irun R. Cohen, Felix Mor
  • Beta-lactam compounds for enhancing T cell-mediated immune responses
    Patent number: 9345691
    Abstract: Compositions and methods are provided, comprising at least one beta-lactam compound selected from the group consisting of cefuroxime, a penicillin, ceftriaxone, clavulanic acid, 6-aminopenicillanic acid (6-APA) and tazobactam, for enhancing T cell mediated immune responses in a subject, such as anti-tumor and anti-viral immune responses.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: May 24, 2016
    Assignee: STEM CELL MEDICINE LTD.
    Inventors: Irun R. Cohen, Felix Mor
  • STEM CELL BANK FOR PERSONALIZED MEDICINE
    Publication number: 20160122709
    Abstract: The present invention relates to a stem cell bank which stores stem cells collected from individuals throughout their entire life. The stem cell bank of the present invention stores stem cells of various types, which are obtained from a plurality of sources from a single individual. The present invention further relates to methods of personalized medicine that utilizes cells stored in a bank of the present invention, and to compositions of stem cells for the treatment of various types of diseases.
    Type: Application
    Filed: January 15, 2016
    Publication date: May 5, 2016
    Applicant: STEM CELL MEDICINE LTD.
    Inventor: Ehud MAROM
  • INSURANCE POLICIES FOR STEM CELLS DEPOSITORS AND METHODS FOR PROVIDING SAME
    Publication number: 20140304012
    Abstract: A method, apparatus and computer program product for generating and applying insurance policies intended to guarantee sufficient amounts of available, viable stem cells to policy holders in case the policy holders are in need of stem cell therapy. An individual may deposit stem cells and give consent to allocate at least some of the stem cells deposited by said individual for public use, and in return be entitled to receive viable stem cells deposited by another individual in case of need.
    Type: Application
    Filed: November 1, 2012
    Publication date: October 9, 2014
    Applicant: STEM CELL MEDICINE LTD
    Inventor: Ehud Marom
  • BETA-LACTAM COMPOUNDS FOR TREATING DIABETES
    Publication number: 20140234282
    Abstract: Compositions and methods comprising ampicillin or salts and derivative thereof for the treatment of delaying the on-set of type I diabetes are provided.
    Type: Application
    Filed: September 20, 2012
    Publication date: August 21, 2014
    Applicant: STEM CELL MEDICINE LTD.
    Inventors: Irun R. Cohen, Felix Mor
  • BETA-LACTAM COMPOUNDS FOR ENHANCING T CELL-MEDIATED IMMUNE RESPONSES
    Publication number: 20140227316
    Abstract: Compositions and methods are provided, comprising at least one beta-lactam compound selected from the group consisting of cefuroxime, a penicillin, ceftriaxone, clavulanic acid, 6-aminopenicillanic acid (6-APA) and tazobactam, for enhancing T cell mediated immune responses in a subject, such as anti-tumor and anti-viral immune responses.
    Type: Application
    Filed: September 20, 2012
    Publication date: August 14, 2014
    Applicant: STEM CELL MEDICINE LTD.
    Inventors: Irun R. Cohen, Felix Mor
  • STEM CELL BANK FOR PERSONALIZED MEDICINE
    Publication number: 20130052169
    Abstract: A stem cell bank is disclosed which stores stem cells collected from individuals throughout their entire life. The stem cell bank stores stem cells of various types, which are obtained from a plurality of sources from a single individual. Also provided are methods of personalized medicine that utilizes cells stored in a bank and compositions of stem cells for the treatment of various types of diseases.
    Type: Application
    Filed: May 5, 2011
    Publication date: February 28, 2013
    Applicant: STEM CELL MEDICINE LTD.
    Inventor: Ehud Marom